TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Keywords

Genome-wide association studySingle-nucleotide polymorphismMultiple sclerosisDiseaseRheumatoid arthritisSNPGenetic associationMedicineAutoimmune diseaseAlleleGeneticsBioinformaticsImmunologyBiologyGeneInternal medicineGenotype

Affiliated Institutions

Related Publications

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Daniel Fishman , Gary Faulds , Rachel Jeffery +4 more

During active disease, patients with systemic-onset juvenile chronic arthritis (S-JCA) demonstrate a rise and fall in serum interleukin-6 (IL-6) that parallels the classic quoti...

1998 Journal of Clinical Investigation 2233 citations

IL-6 in Inflammation, Immunity, and Disease

Toshio Tanaka , Masashi Narazaki , T Kishimoto

Interleukin 6 (IL-6), promptly and transiently produced in response to infections and tissue injuries, contributes to host defense through the stimulation of acute phase respons...

2014 Cold Spring Harbor Perspectives in Bi... 4591 citations

Publication Info

Year: 2012
Type: article
Volume: 488
Issue: 7412
Pages: 508-511
Citations: 372
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

372

OpenAlex

Cite This

APA Style

                            
                                
                                    Adam Gregory, 
                                
                                    Calliope A. Dendrou, 
                                
                                    Kathrine E. Attfield
                                
                                et al.
                            
                            (2012). 
                            TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. 
                            Nature
                            , 488
                            (7412)
                            , 508-511.
                            https://doi.org/10.1038/nature11307
                        

Identifiers

DOI: 10.1038/nature11307